David Pardoe

David Pardoe serves as the SVP Head of Global Molecular Architects at Evotec, focusing on the integration of medicinal chemistry and computational technologies to expedite drug discovery. Previously, David held multiple strategic leadership roles at LifeArc, where responsibilities included advancing technology development for drug discovery and leading collaborative initiatives like the Dementia Consortium. David's career also features impactful positions at adMare BioInnovations, PA Consulting Group, and GSK, where expertise in pharmaceutical discovery strategies, technology development, and medicinal chemistry was honed. David holds a PhD in Medicinal Chemistry from the University of Bristol and a BSc (Hons) in Applied Chemistry from Nottingham Trent University.